<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01401608</url>
  </required_header>
  <id_info>
    <org_study_id>PM-CLIN-015</org_study_id>
    <nct_id>NCT01401608</nct_id>
  </id_info>
  <brief_title>Stereotaxis Idiopathic Ventricular Tachycardia (VT) Study</brief_title>
  <official_title>RF Ablation of Idiopathic VT and PVCs Using Remote Magnetic Navigation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stereotaxis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stereotaxis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess the outcomes of using magnetic navigation to treat ventricular&#xD;
      tachycardia (VT) or premature ventricular contractions (PVCs) that occur for unknown reasons&#xD;
      and are not related to structural heart disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During conventional ventricular arrhythmia ablation procedures, simply contacting the cardiac&#xD;
      wall can significantly alter the electrocardiogram. Induction of ventricular ectopy is&#xD;
      important in determining the focus of the arrhythmogenic tissue during an electrophysiology&#xD;
      (EP) procedure; however, instrumentation with stiff ablation catheters can temporarily&#xD;
      eliminate VT during the mapping portion of the procedure making it difficult to track the&#xD;
      arrhythmia prior to ablating the tissue responsible for its genesis. The catheters used with&#xD;
      the Stereotaxis Magnetic Navigation System (MNS) are less stiff compared to manual catheters&#xD;
      since no pull wires are required to deflect the distal tip. Large external magnets positioned&#xD;
      on either side of the EP procedure table create a magnetic field within the patient's chest.&#xD;
      These large magnets (in direct relationship to the magnetic field) can be manipulated using&#xD;
      specialized software. The physician controls the distal tip of the catheter by using the&#xD;
      software while remotely using a catheter advancing system (QuickCASÂ®, Stereotaxis, Inc, St.&#xD;
      Louis, MO) to reach the desired location within the heart. The soft catheters may provide a&#xD;
      unique quality to the electrophysiologist who may assist by providing accurate maps without&#xD;
      temporarily eliminating the ventricular ectopy due to excessive mechanical forces applied to&#xD;
      the cardiac tissue. This study will assess the physician's ability to appropriately map and&#xD;
      ablate the ventricular substrate using remote magnetic technology. All devices are approved&#xD;
      by FDA and no off-label use of the products is mandated within the protocol.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Difficult to recruit eligible subjects&#xD;
  </why_stopped>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in 24-hour Holter Monitor (number of extra ventricular beats)</measure>
    <time_frame>Change from Holter Monitor Pre-procedure vs. 6-Months Post-procedure</time_frame>
    <description>Use of the MNS in mapping and ablation of idiopathic VT will lead to a 75% reduction in the number of individual ventricular ectopic beats 6 months after the procedure. Extra ventricular beats will be counted using a 24-hour Holter monitor pre-procedure (obtained no more than 30 days prior to the procedure) compared to a 24-hour Holter monitor 6 months post-procedure.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">6</enrollment>
  <condition>Ventricular Tachycardia</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <description>Ablation of VT/PVCs using a magnetic RF ablation catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RF Ablation</intervention_name>
    <description>Ablation of arrhythmogenic ventricular tissue</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>ThermoCool</other_name>
    <other_name>Niobe</other_name>
    <other_name>Stereotaxis</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be diagnosed with any ventricular tachycardia or symptomatic PVCs of&#xD;
        non-ischemic origin.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients must be between 18 - 80 years of age&#xD;
&#xD;
          -  Willing to provide written informed consent&#xD;
&#xD;
          -  Present with ventricular ectopy of non-ischemic origin&#xD;
&#xD;
          -  able to be safely exposed to a static magnetic field&#xD;
&#xD;
          -  Failure of at least 1 antiarrhythmic medication&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of a mobile ventricular thrombus&#xD;
&#xD;
          -  Unable to obtain percutaneous access to the left ventricle&#xD;
&#xD;
          -  Contraindicated for short-term anticoagulation therapy&#xD;
&#xD;
          -  Life expectancy less than 1 year&#xD;
&#xD;
          -  Body habitus limits placement on the procedure table&#xD;
&#xD;
          -  Previously failed ablation procedure for VT/PVCs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raul Weiss, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <study_first_submitted>July 20, 2011</study_first_submitted>
  <study_first_submitted_qc>July 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 25, 2011</study_first_posted>
  <last_update_submitted>May 18, 2015</last_update_submitted>
  <last_update_submitted_qc>May 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>VT</keyword>
  <keyword>ventricular tachycardia</keyword>
  <keyword>ablation</keyword>
  <keyword>magnetic navigation</keyword>
  <keyword>robotic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

